![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
Advertisement
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px](/banner/iito-20181119-650-065-lsus-life-sciences-usa-com.jpg)
Persons > All
Find below all kinds of persons.Total search results: 6915 | Ordered by Person (ascending)
1 2 3 ... 19 20 21 ... 68 69 70 
  Person |
 Position |
Organisation (Group) |
Country |
|---|---|---|---|
| Gilardi, John (Qiagen 201211 Investor Relations) | Public Relations Manager / Investor Relations Manager | Qiagen (Group) | Germany |
| Gilbert, Dennis (Applied Biosystems 200610 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Thermo Fisher (Group) | Germany |
| Gilbert, Walter (Biogen 199811 Founder) | Company Founder | Biogen (Group) | United States (USA) |
| Gildehaus, Nina (Qiagen 200802 Assoc Global Product Manager Plasmid DNA Purification) | Product Manager (personnel) | Qiagen (Group) | Germany |
| Gilham, Ian D. (Axis-Shield 200801 CEO– before COO) | Chief Executive Officer (CEO) | Alere (Group) | United Kingdom (GB) |
| Gilka-Bötzow, Bertram (S-Refit 201107) | Investment Manager | Sparkassen-Finanzgruppe (DE) [FICTIVE UNIT, NOT OFFICIAL GROUP!] (Group) | Germany |
| Gillandt, Hartmut (SiChem GmbH 2001–200902– Managing Director) | Managing Director | Sirius Fine Chemicals SiChem GmbH | Germany |
| Gillessen, Dieter (Arpida 200505 Senior VP + COO) | Chief Operating Officer (COO) | Evolva (Group) | Switzerland |
| Gilleßen, Bernhard (Helmholtz 201112 Projektträger Jülich) | n. a. | Helmholtz-Gemeinschaft (HGF) (Group) | Germany |
| Gilman, Michael (Arrakis Therapeutics 201702– CEO before Padlock Therapeutics 201501 CEO) | Chief Executive Officer (CEO) | Arrakis Therapeutics Inc. | United States (USA) |
| Gin, Gregory (Affimed 201808 Head of Investor Relations) | Public Relations Manager / Investor Relations Manager | Affimed (Group) | Germany |
| Giordanetto, Fabrizio (Taros Chemicals 201309– Director of Medicinal Chemistry before AstraZeneca + Pharmacia/Pfizer) | Research & Development Manager | Taros Chemicals GmbH & Co. KG | Germany |
| Girling, Peter (CellnTec 201307 VP Stratetgic Development + Co-founder) | Corporate Strategy Manager | CellnTec Advanced Cell Systems AG | Switzerland |
| Girod, Patrick (Herculis Partners 201702 Managing Partner) | Managing Partner (investment firm) | Herculis Partners S.A. | |
| Girod, Pierre-Alain (Selexis 201610 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | JSR Corporation (Group) | Switzerland |
| Giroud, Gérard (European Patent Office 200503) | n. a. | European Patent Organisation (EPO) | Germany |
| Girsault, Hervé (Piqur Therapeutics 201306c– Business Development + Licensing Manager before Synosis + Novartis) | Business Development Manager / Strategy Manager | Piqur Therapeutics AG | Switzerland |
| Girshik, Birgit (Charles River 201703 SVP Global Discovery) | President/Director/Head Business Group/Unit/Division | Charles River (Group) | United States (USA) |
| Gitzinger, Marc (BioVersys 2008– CEO + Co-founder) | Chief Executive Officer (CEO) | BioVersys AG | Switzerland |
| Gizler, Gerhard (Niedersachsen (govt) 200912 Managing Director NGlobal GmbH) | Managing Director | Niedersachsen (govt region) | Germany |
| Gladwell, Mark (Qiagen 201710c– SVP Global Operations before Alere Inc) | Board member, executive | Qiagen (Group) | Germany |
| Glanemann, Christoph (Trenzyme GmbH 201202 Lead Scientist + FPPM project manager) | Researcher (industry) | Trenzyme (Group) | Germany |
| Glas, Adrian (Peptide Specialty Laboratories GmbH 201909 CEO) | Chief Executive Officer (CEO) | Peptide Specialty Laboratories GmbH | Germany |
| Glass, Steve (BioMarin Europe 200801– VP + General Manager before Altana) | Managing Director | BioMarin (Group) | United Kingdom (GB) |
| Gleba, Yurijus (Yuri) (Icon Genetics 200501 CEO) | Chief Executive Officer (CEO) | Denka (Group) | Germany |
| Gleeson, Martin (Genalyte 201209 VP Development + Applications) | n. a. | Genalyte Inc. | United States (USA) |
| Glick, Gary D. (IFM Therapeutics 201610 CEO) | Chief Executive Officer (CEO) | Bristol-Myers Squibb (BMS) (Group) | United States (USA) |
| Glieder, Anton (ACIB GmbH 201108 Managing Director) | Managing Director | ACIB GmbH – Austrian Centre of Industrial Biotechnology | Austria |
| Gligor, Mark (Helmholtz 201206 Biotechnologie Strategie BIO1 at Projektträger Jülich at FZ Jülich) | n. a. | Helmholtz-Gemeinschaft (HGF) (Group) | Germany |
| Glinca, Serghei (CrystalsFirst 201709) | n. a. | CrystalsFirst (DE, not yet incorporated) | Germany |
| Glinka, Jacek (Mylan 201312– President of European Business before Polpharma Group CEO) | President/Director/Head Business Group/Unit/Division | Mylan (Group) | United States (USA) |
| Glombitza, Stefan (Formycon 201610– COO) | Chief Operating Officer (COO) | Formycon (Group) | Germany |
| Glund, Konrad (Probiodrug 1997–201804 Founder + CEO 2008 RETIRED 5/18) | Chief Executive Officer (CEO) | Vivoryon (Group) | Germany |
| Gläser-Fischer, Kerstin (Thermo Fisher Scientific, D 200809) | Sales Manager / Marketing Manager | Thermo Fisher (Group) | Germany |
| Glöckner, Frank Oliver (MPI Bremen + Jacobs Univ Bremen + Ribocon GmbH) | Professor | Max Planck Society for the Advancement of Science | Germany |
| Glöggler, Klaus (DeklaTec GmbH 201110 Managing Director) | Managing Director | DeklaTec GmbH | Germany |
| Glöggler, Sabine (Candor Bioscience 201310 Marketing + Communication) | Sales Manager / Marketing Manager | Candor Bioscience GmbH | Germany |
| Gmuender, Marcel (Roche 201706 Global Head Diabetes Care) | President/Director/Head Business Group/Unit/Division | Roche (Group) | Switzerland |
| Gnad-Vogt, Ulrike (CureVac 201710 CMO) | Chief Medical Officer (CMO) | CureVac (Group) | Germany |
| Gockel, Peter (ChemCon GmbH 201209 Managing Director) | Managing Director | ChemCon GmbH | Germany |
| Godde, Dirk (Digomed GmbH 201305 Managing Director) | Managing Director | Digomed: Medical IT – Solutions GmbH | Germany |
| Godet, Franck (Wieland Capital 201811 Managing Partner before BNP Paribas + CSFB + DLJ + Paribas) | Managing Partner (investment firm) | Wieland Capital GmbH & Co. KG | Germany |
| Godewerth, Thelse (Eppendorf 201801– VP Corp Human Resources + Organisational Development) | n. a. | Eppendorf (Group) | Germany |
| Godl, Klaus (Kinaxo 200910 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Evotec (Group) | Germany |
| Godula, Michal (Thermo Fisher 201304 Marketing Manager Food Safety and Environmental Applications) | Sales Manager / Marketing Manager | Thermo Fisher (Group) | United States (USA) |
| Goebel, Frank (BRAIN 201703–201812c CFO joined 201502 before Royal Bank of Scotland WANTS TO LEAVE 8/18) | Chief Financial Officer (CFO) | BRAIN (Group) | Germany |
| Goebel, Werner (Universität Würzburg 200504) | n. a. | University of Würzburg | Germany |
| Goedesky, George (Bruker 201009 Exec Director Marketing + BusDev MALDI Biotyper) | Sales Manager / Marketing Manager | Bruker Corporation (Group) | United States (USA) |
| Goetz, Wolfgang (Transcatheter Technologies 201105 CEO) | Chief Executive Officer (CEO) | Transcatheter Technologies GmbH | Germany |
| Goff, Marcia (Thermo Fisher –201805 LEFT) | n. a. | Thermo Fisher (Group) | United States (USA) |
| Gohlke, Rüdiger (GSG Mess- und Analysengeräte 200803 Managing Director) | Managing Director | GSG Mess- und Analysengeräte GmbH | Germany |
| Gohm, Harald (Tirol (govt) 201105 Standortagentur Tirol Managing Director) | Managing Director | Tirol (govt region) | Austria |
| Goig, André (Syngenta 201306 Regional Director EAME + Chairman of EuropaBio since 201306) | Regional manager | Syngenta (Group) | Switzerland |
| Goker, Hakan (Merck (DE) 201509 Senior Investment Direcotor MS Ventures before Aescap Venture + Atlas Venture) | Investment Manager | Merck (DE) (Group) | Germany |
| Gold, Ludwig (Miracor 201407 CEO) | Chief Executive Officer (CEO) | Miracor (Group) | Austria |
| Goldenstein, Lissa (Auxogyn 201210 CEO) | Chief Executive Officer (CEO) | Auxogyn Inc. | United States (USA) |
| Goldman, Jonathan (Aptuit 201604 CEO) | Chief Executive Officer (CEO) | Evotec (Group) | United States (USA) |
| Goldman, Michel (Innovative Medicines Initiative 201103 Executive Director) | President/Director/Head Business Group/Unit/Division | Innovative Medicines Initiative (IMI) | EU (European Union) |
| Goldschmidt, Colin (Sonic Healthcare 201701 CEO + Managing Director) | Chief Executive Officer (CEO) | Sonic Healthcare (Group) | Australia |
| Goldsmith, Neil (Evolva –200910–201707 CEO STEPPED DOWN 7/17) | Chief Executive Officer (CEO) | Evolva (Group) | Switzerland |
| Goletz, Steffen (Glycotope 201601– CSO before since 200809 Managing Director + Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Glycotope (Group) | Germany |
| Goll, Alexandra (TVM 200512) | General Partner (venture partner) | TVM (Group) | Germany |
| Golla, Stephan (Univ of Western Sydney 201203) | n. a. | University of Western Sydney (UWS) | Australia |
| Goller, Alexandra (MorphoSys 201803 Associate Director Corp Comm & IR) | Public Relations Manager / Investor Relations Manager | MorphoSys (Group) | Germany |
| Golson, Russell (Biognosys 201401– Director of Sales before BioSilta + Febit + MWG Biotech) | Sales Manager / Marketing Manager | Biognosys AG | Switzerland |
| Golumbeski, George (Celgene 201804 EVP + Executive Advisor for Innovation + proposed to MorphoSys Supervisory Board) | President/Director/Head Business Group/Unit/Division | Celgene (Group) | United States (USA) |
| Gombert, Till (Protectimmun 200808 Founder) | Company Founder | Protectimmun GmbH | Germany |
| Gonçalves, Dulce (Auven Therapeutics 201409– Corporate Counsel at ADC Therapeutics before Novartis) | General Counsel / Chief Legal Officer (CLO) | ADC Therapeutics (Group) | Switzerland |
| Gooch, Daniel (Instinctif Partners 201509) | Public Relations Manager / Investor Relations Manager | Instinctif Partners (Group) | United Kingdom (GB) |
| Goodwin, Elizabeth (Galapagos 201112 Director Investor Relations) | Public Relations Manager / Investor Relations Manager | Galapagos (Group) | Belgium |
| Gorbachev, Maxim (Russia (govt) 201501 Partner at RMI Partners) | Partner (venture partner) | Russia (govt) | Russian Federation |
| Gordon, Carl L. (OrbiMed Advisors 201509 Partner) | Partner (venture partner) | OrbiMed (Group) | United States (USA) |
| Gordon, Jenn (Global Health PR 201901) | Public Relations Manager / Investor Relations Manager | Global Health PR (US) | United States (USA) |
| Gordon, Steven J. (Intelligent Bio-Systems 201206 CEO + founder) | Chief Executive Officer (CEO) | Qiagen (Group) | United States (USA) |
| Goris, Ludwig (Capricorn Venture Partners 201808 Investment Manager) | Investment Manager | Capricorn Venture Partners (Group) | Belgium |
| Gorzka, Gabriele (Univ Kassel 201108 Head of OWWZ) | President/Director/Head Business Group/Unit/Division | University of Kassel | Germany |
| Goschin, Jörg (Alstin GmbH 201108– Managing Director before Blackstone Group London + Cerberus Capital) | Managing Director | MASCHMEYER Group (family Maschmeyer) | Germany |
| Gossé, Jörn (Körber 201905 CEO of Körber Medipak Systems) | Chief Executive Officer (CEO) | Körber (Group) | Germany |
| Gotteland, Jean-Pierre (ObsEva 201701 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | ObsEva (Group) | Switzerland |
| Gottraux, Jean-Claude (Roche 201404 Head of Roche Professional Diagnostics) | President/Director/Head Business Group/Unit/Division | Roche (Group) | Switzerland |
| Gottschalk, Gerhard | n. a. | Project »Genomforschung an Mikroorganismen zur Analyse und Nutzung der Biodiversität« (Kompetenznetz, Uni Göttingen) | Germany |
| Gottschalk, Uwe (Lonza 201406– CTO of Lonza Pharma&Biotechbefore Sartorius Stedim Biotech + Bayer Heatlhcare) | Chief Technology/Technical Officer (CTO) | Lonza Group (Group) | Switzerland |
| Gouliaev, Alex Haahr (Nuevolution 201205 CEO + Co-founder before NeuroSearch) | Chief Executive Officer (CEO) | Nuevolution (Group) | Denmark |
| Goundis, Dimitri (MaxiVax 201602– CEO before Acrongenomics + Speedel + Medicines Co Inc + Roche) | Chief Executive Officer (CEO) | MaxiVax S.A. | Switzerland |
| Graber, Armin (Biocrates 200502 Managing Director) | Managing Director | Biocrates (Group) | Austria |
| Grabert, Sebastian (Euronext 201709 Director Germany Representative before HSCBC + Berenberg) | Sales Manager / Marketing Manager | Euronext (Group) | Netherlands |
| Grabulovski, Dragan (Covagen 200701– CSO + co-founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Johnson & Johnson (JnJ) (Group) | Switzerland |
| Gradnik, Roberto (Merck Serono –200708– Head of Operations Europe) | n. a. | Merck (DE) (Group) | Germany |
| Graewe, Thomas (Amedrix 201109 Managing Director) | Managing Director | Amedrix GmbH | Germany |
| Graf von Stosch, Andreas (Bosch Graf von Stosch Jehle 200809) | n. a. | Bosch Graf von Stosch Jehle (Munich) | Germany |
| Graf, Marcus (Geneart 199911– co-founder + 5/06 head Bus Unit gene synthesis) | President/Director/Head Business Group/Unit/Division | Thermo Fisher (Group) | Germany |
| Graf, Peter (Bavaria (govt) 201902 Investment Manager at BayBG) | Investment Manager | BayBG Bayerische Beteiligungsgesellschaft mbH | Germany |
| Graham, John (Menarini 201504 Chief Executive of Menarini Asia-Pacific Pte Ltd) | Chief Executive Officer (CEO) | Menarini (Group) | Singapore |
| Graimann, Bernhard (Otto Bock 201009) | n. a. | Ottobock (Otto Bock) (Group) | Germany |
| Grainger, David (Medixci Ventures 201602– General Partner before Index Ventures 2012– + Funxional Therapeutics) | General Partner (venture partner) | Medicxi Ventures (formerly Index Ventures Life Sciences) | United Kingdom (GB) |
| Gramatica, Ruggero (Therametrics –201309 CEO RESIGNED 9/13) | Chief Executive Officer (CEO) | Relief Therapeutics (Group) | Switzerland |
| Grandidier, Laurent (Xeltis 201412 CEO) | Chief Executive Officer (CEO) | Xeltis (Group) | Switzerland |
| Granger, Chris (Immunotec 200508 Director of Sales) | Sales Manager / Marketing Manager | IMMUNOTEC Immunologisch-technische Produkt- und Beratungs GmbH | Germany |
| Granier, Benoit (Unisensor (BE) 201805 CEO) | Chief Executive Officer (CEO) | Unisensor S.A. (BE) | Belgium |
| Grant, Nick (AMETEK 201610 VP Material Analysis Division) | President/Director/Head Business Group/Unit/Division | AMETEK (Group) | United States (USA) |
1 2 3 ... 19 20 21 ... 68 69 70
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
